1. Home
  2. AMCX vs LRMR Comparison

AMCX vs LRMR Comparison

Compare AMCX & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMCX
  • LRMR
  • Stock Information
  • Founded
  • AMCX 1980
  • LRMR N/A
  • Country
  • AMCX United States
  • LRMR United States
  • Employees
  • AMCX N/A
  • LRMR N/A
  • Industry
  • AMCX Cable & Other Pay Television Services
  • LRMR Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMCX Telecommunications
  • LRMR Health Care
  • Exchange
  • AMCX Nasdaq
  • LRMR Nasdaq
  • Market Cap
  • AMCX 375.2M
  • LRMR 426.9M
  • IPO Year
  • AMCX 2011
  • LRMR N/A
  • Fundamental
  • Price
  • AMCX $9.37
  • LRMR $4.01
  • Analyst Decision
  • AMCX Hold
  • LRMR Strong Buy
  • Analyst Count
  • AMCX 3
  • LRMR 8
  • Target Price
  • AMCX $9.33
  • LRMR $19.63
  • AVG Volume (30 Days)
  • AMCX 645.8K
  • LRMR 1.1M
  • Earning Date
  • AMCX 02-07-2025
  • LRMR 10-30-2024
  • Dividend Yield
  • AMCX N/A
  • LRMR N/A
  • EPS Growth
  • AMCX N/A
  • LRMR N/A
  • EPS
  • AMCX 0.79
  • LRMR N/A
  • Revenue
  • AMCX $2,500,857,000.00
  • LRMR N/A
  • Revenue This Year
  • AMCX N/A
  • LRMR N/A
  • Revenue Next Year
  • AMCX N/A
  • LRMR N/A
  • P/E Ratio
  • AMCX $11.90
  • LRMR N/A
  • Revenue Growth
  • AMCX N/A
  • LRMR N/A
  • 52 Week Low
  • AMCX $7.08
  • LRMR $3.01
  • 52 Week High
  • AMCX $19.55
  • LRMR $13.68
  • Technical
  • Relative Strength Index (RSI)
  • AMCX 50.90
  • LRMR 25.50
  • Support Level
  • AMCX $9.13
  • LRMR $3.83
  • Resistance Level
  • AMCX $9.99
  • LRMR $6.91
  • Average True Range (ATR)
  • AMCX 0.46
  • LRMR 0.57
  • MACD
  • AMCX -0.06
  • LRMR -0.22
  • Stochastic Oscillator
  • AMCX 34.62
  • LRMR 25.64

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached nearly 65 million pay-TV households in the US at the end of 2023. The firm also had nearly 11.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: